Reporter July 2023

July 18, 2023

VUMC receives $7 million award from PCORI to compare breathing tube sedation

Vanderbilt University Medical Center has received a $7 million, five-year funding award from the Patient-Centered Outcomes Research Institute to compare two sedatives used to place breathing tubes in the emergency department or intensive care unit.

July 18, 2023

The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer and Merck

Illumina Inc., in collaboration with Nashville Biosciences LLC, a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, have announced the five founding new members of the Alliance for Genomic Discovery.

Ann Walker, Research Assistant III, spins blood samples on a carousel prior to DNA extraction.
July 18, 2023

Alliance for Genomic Discovery FAQs

Here are frequently asked questions about Vanderbilt University Medical Center’s Alliance for Genomic Discovery.

July 17, 2023

Academy for Excellence in Education elects 13 new members

Vanderbilt University Medical Center’s Academy for Excellence in Education has elected 13 new members for 2023.

July 17, 2023

Alzheimer’s genetic risk tracked across sex, race

A Vanderbilt study of genetic risks for cognitive impairment later in life uses data from 32,426 research participants ages 60 and older to elaborate these risks across sex and across the intersection of sex and race.

July 17, 2023

World-first clinical trial to help millions with penicillin allergies

Many low-risk patients with a penicillin allergy were able to have their penicillin allergy label removed through a simple procedure known as “direct oral challenge” as part of a world-first multicenter randomized control trial known as the Penicillin Allergy Clinical Decision Rule (PALACE) study.